期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Surgical Treatment of Small Intestinal Bleeding Caused by Arterial Gastrointestinal Fistula: A 2-Case Report
1
作者 Maieryemu Sulaiman sakarie mustafe hidig +2 位作者 Jie Yang Tianshan Wu Xiaokaiti Yibulayin 《Case Reports in Clinical Medicine》 2023年第4期81-87,共7页
Background: This study aims to better understand diagnosing and treating arterial gastrointestinal fistulas. Methods: The diagnosis and treatment of two patients with arterial gastrointestinal fistulas were reported, ... Background: This study aims to better understand diagnosing and treating arterial gastrointestinal fistulas. Methods: The diagnosis and treatment of two patients with arterial gastrointestinal fistulas were reported, and the experience with diagnosis and treatment was summarized. Results: In these two cases, both patients were admitted with bleeding as the primary complaint, both underwent emergency laparotomies, and both patients were diagnosed with small intestinal bleeding before surgery. the first patient died as a result of an abdominal aortic aneurysm rupture caused by chronic vascular repair and postoperative implant infection;the second patient underwent vascular repair on time, we treated him with third-generation cephalosporin, and after he was stabilized, we performed left total iliac stent placement and left internal iliac artery embolization;he had no fever after surgery, his incision was healed, and he was successfully discharged from the hospital. Conclusion: Aortic gastrointestinal fistula is rare and has a high mortality rate, attention should be paid to distinguishing it from small intestinal bleeding. Timely diagnosis and rapid surgical treatment are keys to improving survival. 展开更多
关键词 Ileocecal Valve Abdominal Aortic Aneurysms Laparotomy Probe ANGIOGRAPHY Primary Aortoenteric Fistula
下载PDF
地诺单抗在骨巨细胞瘤中的应用研究进展 被引量:1
2
作者 田齐 田征 +1 位作者 陈江涛 《陕西医学杂志》 CAS 2021年第6期763-765,F0003,共4页
地诺单抗是一种针对骨巨细胞瘤(GCTB)基质细胞核因子-κB受体活化蛋白(RANK)配体的单克隆抗体,可抑制肿瘤的溶骨性破坏。目前一系列研究已经证明,地诺单抗在扩大病灶刮除术前新辅助降期方面效果良好,对难以手术患者可以行地诺单抗姑息... 地诺单抗是一种针对骨巨细胞瘤(GCTB)基质细胞核因子-κB受体活化蛋白(RANK)配体的单克隆抗体,可抑制肿瘤的溶骨性破坏。目前一系列研究已经证明,地诺单抗在扩大病灶刮除术前新辅助降期方面效果良好,对难以手术患者可以行地诺单抗姑息治疗。但亦有研究表明,相比单纯行病灶刮除术,地诺单抗联合刮除术在术后更可能会局部复发;地诺单抗对肿瘤基质细胞具有一定抑制作用,但不具有杀灭作用;地诺单抗治疗后肿瘤组织出现恶性细胞特征;在地诺单抗给药期间发生恶性肿瘤转变,具体原因还有待进一步研究。现对地诺单抗在GCTB中的应用研究进展进行综述。 展开更多
关键词 骨巨细胞瘤 核因子-κB受体活化蛋白 地诺单抗 姑息治疗 复发
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部